Jason M. Hannon
Directeur Général chez MAINSTAY MEDICAL INTERNATIONAL
Fortune : 49 071 $ au 31/05/2024
Profil
Jason M.
Hannon is currently the President, CEO & Executive Director at Mainstay Medical International Ltd., the Chief Executive Officer & Director at Mainstay Medical Ltd., the Chief Executive Officer & Director at Mainstay Medical Holdings Plc, and an Independent Director at Orthofix Medical, Inc. He previously served as an Independent Non-Executive Director at Kuros Biosciences Ltd.
and Sequana Medical NV.
From 2016 to 2017, he was the President & Chief Operating Officer at NuVasive, Inc. and prior to that, he held the position of Executive Vice President-International at NuVasive Netherlands BV.
Mr. Hannon completed his undergraduate studies at the University of California, Berkeley and obtained a graduate degree from Stanford Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ORTHOFIX MEDICAL, INC.
0,01% | 22/04/2024 | 3 574 ( 0,01% ) | 49 071 $ | 31/05/2024 |
Postes actifs de Jason M. Hannon
| Sociétés | Poste | Début |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Directeur Général | 09/10/2017 |
| ORTHOFIX MEDICAL INC. | Directeur/Membre du Conseil | 08/06/2020 |
Mainstay Medical Ltd.
 Mainstay Medical Ltd. Medical SpecialtiesHealth Technology Mainstay Medical Ltd. operates as a medical device company which develops neuro-stimulation therapies for people with debilitating chronic low back pain. It develops ReActiv8, an active implantable medical device designed to treat people with chronic low back pain. The company was founded by Danny Sachs in 2008 and is headquartered in Dublin, Ireland. | Directeur Général | - |
Mainstay Medical Holdings Plc
 Mainstay Medical Holdings Plc Financial ConglomeratesFinance Mainstay Medical Holdings Plc is a medical device company, which focuses on commercializing an innovative implantable restorative neurostimulation system, ReActiv8, for people with disabling mechanical Chronic Low Back Pain. The company was founded in 2020 and is headquartered in Dublin, Ireland. | Directeur Général | - |
Anciens postes connus de Jason M. Hannon
| Sociétés | Poste | Fin |
|---|---|---|
| NUVASIVE, INC. | President | 01/08/2017 |
| SEQUANA MEDICAL N.V. | Directeur/Membre du Conseil | - |
| KUROS BIOSCIENCES AG | Directeur/Membre du Conseil | - |
| NuVasive Netherlands BV | Corporate Officer/Principal | - |
Formation de Jason M. Hannon
| University of California, Berkeley | Undergraduate Degree |
| Stanford Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ORTHOFIX MEDICAL INC. | Health Technology |
| KUROS BIOSCIENCES AG | Health Technology |
| SEQUANA MEDICAL N.V. | Health Technology |
| Entreprise privées | 5 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
Mainstay Medical International Ltd.
 Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Mainstay Medical International Ltd. is a medical device company, which is engages in the development of neurostimulation system. It focuses on the study of ReActiv8, a medical device designed to treat people with chronic low back pain. The company was founded by Danny Sachs in 2008 and is headquartered in San Diego, CA. | Health Technology |
Mainstay Medical Ltd.
Mainstay Medical Ltd. Medical SpecialtiesHealth Technology Mainstay Medical Ltd. operates as a medical device company which develops neuro-stimulation therapies for people with debilitating chronic low back pain. It develops ReActiv8, an active implantable medical device designed to treat people with chronic low back pain. The company was founded by Danny Sachs in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| NuVasive Netherlands BV | |
Mainstay Medical Holdings Plc
Mainstay Medical Holdings Plc Financial ConglomeratesFinance Mainstay Medical Holdings Plc is a medical device company, which focuses on commercializing an innovative implantable restorative neurostimulation system, ReActiv8, for people with disabling mechanical Chronic Low Back Pain. The company was founded in 2020 and is headquartered in Dublin, Ireland. | Finance |
